Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diffuse Large B-Cell Lymphoma.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02205333
What this trial is testing

A Phase 1b/2 Safety and Tolerability Study of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies

Who this might be right for
Advanced Solid TumorsAggressive B-cell Lymphomas
MedImmune LLC 48
Testing effectiveness (Phase 2)Looking for participantsNCT06375733
What this trial is testing

GFH009 in Combination With Zanubrutinib in Subjects With Relapsed or Refractory DLBCL

Who this might be right for
Large B-cell Lymphoma
Genfleet Therapeutics (Shanghai) Inc. 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT03147885
What this trial is testing

Selinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin Lymphoma

Who this might be right for
Diffuse Large B-Cell LymphomaRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Extranodal Marginal Zone Lymphoma+12 more
Barbara Ann Karmanos Cancer Institute 43
Testing effectiveness (Phase 2)WithdrawnNCT05222438
What this trial is testing

Trial of Loncastuximab Tesirine in High Risk Diffuse Large B-cell Lymphoma Post Transplant

Who this might be right for
Relapsed Diffuse Large B-cell Lymphoma
Barbara Ann Karmanos Cancer Institute
Not applicableNot Yet RecruitingNCT07476378
What this trial is testing

Evaluate MTM-H-001 Injection in Adult Participants With Relapsed or Refractory B-cell Malignancies

Who this might be right for
Lymphoma, Large B-Cell, Diffuse (DLBCL)Lymphoma, FollicularLymphoma, Mantle-Cell+3 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 69
Large-scale testing (Phase 3)UnknownNCT03650933
What this trial is testing

A Study Comparing the Efficacy and Safety of G-CHOP Versus R-CHOP in Untreated Diffuse Large B-cell Lymphoma Patients

Who this might be right for
Diffuse Large B-Cell Lymphoma, Unspecified Site
Nanjing Yoko Biomedical Co., Ltd. 360
Testing effectiveness (Phase 2)WithdrawnNCT05966233
What this trial is testing

R-DHAP vs POLA-R-DHAP Followed by Autologous Transplant as First Salvage Treatment in Patient With Relapsed or Refractory Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma RefractoryDiffuse Large B-cell Lymphoma Recurrent
Fondazione Italiana Linfomi - ETS
Testing effectiveness (Phase 2)Study completedNCT00724984
What this trial is testing

Study of the Safety and Tolerability of PCI-24781 in Patients With Lymphoma

Who this might be right for
LymphomaHodgkin DiseaseLymphoma, Non-Hodgkin
Pharmacyclics LLC. 55
Not applicableStudy completedNCT04695366
What this trial is testing

The Potential of Patient-reported Outcome Measures in Detection of Relapse in Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B Cell LymphomaPatient Reported Outcome
Herlev Hospital 250
Early research (Phase 1)Study completedNCT00003451
What this trial is testing

Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
National Cancer Institute (NCI) 40
Large-scale testing (Phase 3)UnknownNCT02772822
What this trial is testing

A Study Comparing the Efficiency and Safety of S-CHOP(Cyclophosphamide, Hydroxydaunomycin, Oncovin, and Prednisone) Versus R-CHOP in Untreated CD20(Cluster of Differentiation Antigen 20)-Positive DLBCL Patients

Who this might be right for
Diffuse Large B Cell Lymphoma
Sinocelltech Ltd. 330
Large-scale testing (Phase 3)Study completedNCT03570892
What this trial is testing

Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma

Who this might be right for
Non-Hodgkin Lymphoma
Novartis Pharmaceuticals 330
Testing effectiveness (Phase 2)Study completedNCT00058422
What this trial is testing

Rituximab and Combination Chemotherapy Combined With Yttrium Y 90 Ibritumomab Tiuxetan in Treating Older Patients With Previously Untreated B-Cell Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center 65
Testing effectiveness (Phase 2)Study completedNCT00727831
What this trial is testing

Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma

Who this might be right for
Chemotherapeutic Agent ToxicityLymphomaMucositis+1 more
University College, London 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT05221645
What this trial is testing

Pembrolizumab in Combination With R-ICE Chemotherapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma
University of Southampton 65
Testing effectiveness (Phase 2)Study completedNCT00225212
What this trial is testing

Rituximab After Autologous Stem Cell Transplant for Relapsed B-cell Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's LymphomaDiffuse Large Cell LymphomaMantle Cell Lymphoma+3 more
Stanford University 35
Not applicableLooking for participantsNCT07198230
What this trial is testing

Drug-Eluting Bead-Based Transarterial Chemoembolization (DEB-TACE) as a Local Salvage Therapy for Large Lesions in Relapsed and Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell LymphomaRelapsed and RefractoryTransarterial Chemoembolization
Ting YANG 10
Testing effectiveness (Phase 2)Ended earlyNCT01116232
What this trial is testing

Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
Barbara Ann Karmanos Cancer Institute 4
Testing effectiveness (Phase 2)Study completedNCT01472887
What this trial is testing

SAR3419 as Single Agent in Relapsed-Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients

Who this might be right for
Diffuse Large B-cell Lymphoma
Sanofi 61
Early research (Phase 1)Looking for participantsNCT05052528
What this trial is testing

Fludarabine and Cyclophosphamide With or Without Rituximab Before CD19 Chimeric Antigen Receptor T Cells for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma
University of California, Davis 36
Next Page